July 12 (Reuters) - Immunovaccine Inc IMV.TO
* Immunovaccine achieves breakthrough in support of developing personalized cancer immunotherapies
* Immunovaccine Inc - filed a patent application covering the novel DepoVax-based rapid formulation process Source text for Eikon: ID:nGNXOAARYa Further company coverage: IMV.TO